Caisse DE Depot ET Placement DU Quebec Sells 67,902 Shares of Humana Inc. (NYSE:HUM)

Caisse DE Depot ET Placement DU Quebec decreased its stake in shares of Humana Inc. (NYSE:HUM) by 27.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 183,712 shares of the insurance provider’s stock after selling 67,902 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Humana were worth $58,189,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the stock. Pzena Investment Management LLC boosted its position in shares of Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955,375 shares in the last quarter. Marshall Wace LLP raised its stake in Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the period. International Assets Investment Management LLC boosted its holdings in Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after acquiring an additional 738,701 shares in the last quarter. FMR LLC grew its stake in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares during the period. Finally, Baupost Group LLC MA bought a new stake in shares of Humana during the second quarter valued at approximately $156,933,000. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on HUM shares. JPMorgan Chase & Co. upped their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Royal Bank of Canada dropped their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $315.86.

Humana Price Performance

Shares of NYSE HUM opened at $296.38 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $504.79. The stock has a market cap of $35.69 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. The stock has a fifty day moving average of $275.33 and a 200-day moving average of $329.36.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Equities research analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.